| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |